+92 (51)2275210
Allergy Center @   All Rights Reserved
+92 (51)2804423


Dr.Shahid Abbas
ex Chief CTDRD, NIH,
CPC Heart Care Center
Preventive & Non surgical Treatment of Heart & Arterial Diseases

by Elmer M. Cranton, M.D.
Intravenous edta chelation therapy, a simple office procedure using ethylene diamine tetraacetic acid (EDTA), reverses and slows progression of atherosclerotic heart disease, hardening of the arteries, and other age-related and degenerative diseases. Symptoms affecting many different parts of the body often improve, for reasons that are not yet fully understood. Blood flow increases in blocked coronary arteries to the heart, to the brain, to the legs, and all throughout the body. Heart attacks, strokes, leg pain and gangrene can often be helped or  avoided using this therapy. Need for bypass surgery and balloon angioplasty often disappears after chelation. Published research also shows that chelation therapy acts as a preventive against cancer <>.

The free radical theory of disease (caused by oxygen free radicals) provides one scientific explanation for the many observed benefits following chelation therapy. Many scientific studies published in peer reviewed medical journals provide solid clinical evidence for benefit. This non-invasive therapy is very much safer and far less expensive than surgery or angioplasty.

Chelation therapy is a safe and effective alternative to bypass surgery, angioplasty and stents. Hardening of the arteries need not lead to coronary bypass surgery, heart attack, amputation, stroke, or senility. There is new hope for victims of these and other related diseases. Despite what you may have heard from other sources, EDTA chelation therapy, administered by a properly trained practitioner, in conjunction with a healthy lifestyle, prudent diet, and nutritional supplements, is an option to be seriously considered by persons suffering from coronary artery disease, cerebral vascular disease, brain disorders resulting from circulatory disturbances, generalized hardening of the arteries (atherosclerosis, also called arteriosclerosis) and related ailments which can lead to stroke, heart attack, senility, gangrene, and accelerated physical decline.

Clinical benefits from chelation therapy vary with the total number of treatments received and with severity of the condition being treated. On average, 85 percent of chelation patients have improved very significantly. More than 90 percent of patients receiving 30 or more chelation infusions have benefited enough to be grateful for this therapy-even more so when they also followed a healthy lifestyle, avoiding the use of tobacco. Symptoms improve, blood flow to diseased organs increases, need for medication often decreases and, most importantly, the quality of life becomes more productive and enjoyable.

When patients first hear about or consider EDTA chelation therapy, they normally have lots of questions. Undoubtedly you do, too. Here are the answers to those most commonly asked questions, explained in non-technical language.


Chelation (pronounced KEY-LAY-SHUN) is the process by which a metal or mineral (such as calcium, lead, cadmium, iron, arsenic, aluminum, etc.) is bonded to another substance?in this case EDTA, an amino acid. It is a natural process, basic to life itself. Chelation is one mechanism by which such common substances as aspirin, antibiotics, vitamins, minerals and trace elements work in the body. Hemoglobin, the red pigment in blood which carries oxygen, is a chelate of iron.


Chelation is a treatment by which a small amino acid called ethylene diamine tetraacetic acid (commonly abbreviated EDTA) is slowly administered to a patient intravenously over several hours, prescribed by and under the supervision of a licensed health care practitioner. The IV fluid containing EDTA is infused through a small needle placed in the vein of a patientís arm. The EDTA infusion bonds with unbalanced metals in the body and quickly redistributes them in a healthy way, or carries them away in the urine. Abnormally situated nutritional metals, such as iron, along with toxic elements such as lead, mercury and aluminum are easily removed by EDTA chelation therapy. Normally present minerals and trace elements which are essential for health are more tightly bound within the body and can be maintained with a properly balanced nutritional supplement.


On the contrary, chelation therapy usually consists of anywhere from 20 to 50 separate infusions, depending on each patientís individual health status. Thirty treatments is the average number required for optimum benefit in patients with symptoms of arterial blockage. Some patients eventually receive more than 100 chelation therapy infusions over several years. Other healthier patients receive only 20 infusions as part of a preventive program. Each chelation treatment takes three hours or longer and patients cannot receive more than one treatment each day. It is the total number of treatments that determine results, not the schedule or frequency. Some patients receive treatments daily and others come weekly or at at variable intervals as convenience and their schedule dictates. Over a period of time, these injections halt the progress of the free radical disease. Free radicals underlie the development of atherosclerosis and many other degenerative diseases of aging. Reduction of damaging free radicals it believed to allow diseased arteries to heal, restoring blood flow. With time chelation therapy brings profound improvement to many essential metabolic and physiologic functions in the body. The bodyís regulation of calcium and cholesterol is restored by normalizing the internal chemistry of cells. Chelation has many favorable actions on the body.

Chelation therapy benefits the flow of blood through every vessel in the body, from the largest to the tiniest capillaries and arterioles, most of which are far too small for surgical treatment or are deep within the brain where they cannot be safely reached by surgery. In many patients, the smaller blood vessels are the most severely diseased, especially in the presence of diabetes. The benefits of chelation occur simultaneously from the top of the head to the bottom of the feet, not just in short segments of a few large arteries which can be bypassed by surgical treatment.


No, chelation therapy is an out-patient treatment available in a physicianís office or clinic.


Being "chelated" is quite a different experience from other medical treatments. There is no pain, and in most cases, very little discomfort. Patients are seated in reclining chairs and can read, nap, watch TV, do needlework, or chat with other patients while the fluid containing the EDTA flows into their veins. If necessary, patients can walk around. They can visit the restroom, eat and drink as they desire, or make telephone calls, being careful not to dislodge the needle attached to the intravenous infusion they carry with them. Some patients even run their businesses by telephone or computer while receiving chelation therapy.


EDTA chelation therapy is relatively non-toxic and risk-free, especially when compared with other treatments. Patients routinely drive themselves home after chelation treatment with no difficulty. The risk of significant side effects, when properly administered, is less than 1 in 10,000 patients treated. By comparison, the overall death rate as a direct result of bypass surgery is approximately 3 out of every 100 patients, varying with the hospital and the operating team. The incidence of other serious complications following surgery is much higher, approaching 25%, including heart attacks, strokes, blood clots, mental impairment, infection, and prolonged pain. Chelation therapy is at least 300 times safer than bypass surgery.

Occasionally, patients may suffer minor discomfort at the site where the needle enters the vein. Some temporarily experience mild nausea, dizziness, or headache as an immediate aftermath of treatment, but in the vast majority of cases, these minor symptoms are easily relieved. When properly administered by a trained health care practitioner expert in this type of therapy, chelation is safer than many other prescription medicines. Statistically speaking, the treatment itself is safer than the drive in an automobile to the doctors office.

If EDTA chelation therapy is given too rapidly or in too large a dose it may cause harmful side effects, just as an overdose of any other medicine can be dangerous. Reports of serious and even rare fatal complications many years ago stemmed from excessive doses of EDTA, administered too rapidly and without proper laboratory monitoring. If you choose a provider with proper training and experience, who is an expert in the use of EDTA, the risk of chelation therapy will be kept to a very low level.

While it has been stated by critics that EDTA chelation therapy is damaging to the kidneys, the newest research (consisting of kidney function tests done on hundreds of consecutive chelation patients, before and after treatment with EDTA for chronic degenerative diseases) indicates the reverse is true. There is, on the average, significant improvement in kidney function following chelation therapy. An occasional patient may be unduly sensitive, however, and practitionersí expert in chelation monitor kidney function with laboratory testing to avoid overloading the kidneys. Chelation treatments must be given more slowly and less frequently if kidney function is not normal. Patients with some types of severe kidney problems should not receive EDTA chelation therapy.


Prior to commencing a course of chelation therapy a complete medical history is obtained. Diet is analyzed for nutritional adequacy and balance. Copies of pertinent medical records and summaries of hospital admissions may be sent for. A thorough head-to-toe, hands-on physical examination will be performed. A complete list of current medications will be recorded, including the time and strength of each dose. Special note will be made of any allergies.

Blood and urine specimens will be obtained in a battery of tests to insure that no conditions exist which should be treated differently or might be worsened by chelation therapy. Kidney function will be carefully assessed. An electrocardiogram is usually obtained. Noninvasive tests will be performed, as medically indicated, to determine the status of arterial blood flow prior to therapy. A consultation with other medical specialists may be requested.


Not at all. Chelation's earliest application with humans was before World War II when the British used another chelating agent, British Anti-Lewesite (BAL), as a poison gas antidote. BAL is related to chelators still used today in medicine.

EDTA was first introduced into medicine in the United States in 1948 as a treatment for industrial workers suffering from lead poisoning in a battery factory. Shortly thereafter, the U.S. Navy advocated chelation therapy for sailors who had absorbed lead while painting government ships and dock facilities. In the years since, chelation therapy has remained the undisputed treatment-of-choice for lead poisoning, even in children with toxic accumulations of lead in their bodies as a result of eating leaded paint from toys, cribs or walls.

In the early 1950ís it was speculated that EDTA chelation therapy might help the accumulations of calcium associated with hardening of the arteries. Experiments were performed and victims of atherosclerosis experienced health improvements following chelation-diminished angina, better memory, sight, hearing and increased vigor. A number of practitioners then began to routinely treat individuals suffering from occlusive vascular conditions with chelation therapy. Consistent improvements were reported for most patients.

Published articles describing successful treatment of atherosclerosis with EDTA chelation therapy first appeared in medical journals in 1955. Dozens of favorable articles have been published since then. No unsuccessful results have ever been reported (with the exception of several recent studies with very flawed data deceptively presented by bypass surgeons, in a seeming attempt to discredit this competing therapy). There have also been a number of editorial comments of a critical nature made by physicians with vested interests in vascular surgery and related procedures.

From 1964 on, despite continued documentation of its benefits and the development of safer treatment methods, the use of chelation for the treatment of arterial disease has been the subject of controversy.


Absolutely. There is no legal prohibition against a licensed medical doctor using chelation therapy for whatever conditions he or she deems it to be in the best interests of their patients, even though the drug involved, EDTA, does not yet have atherosclerosis listed as an indication on the FDA-approved package insert. Contrary to popular belief, the FDA does not regulate the practice of medicine, but merely approves marketing, labeling and advertising claims for drugs and devices sold in interstate commerce.

It costs many millions of dollars to perform the required research and to provide the FDA with documentation for a new drug claim, or even to add a new use to marketing brochures of a long established medicine like EDTA. Physicians routinely prescribe medicines for conditions not included on FDA approved advertising and marketing literature.

The American College for Advancement in Medicine conducts educational courses in the proper and safe use of intravenous EDTA chelation twice yearly. They also publish a
Protocol <> which contains professionally recognized standards of medical practice for chelation therapy.

On the question of legality <>, courts have expressed the opinion that a practitioner who withholds information about the availability of other treatment choices, such as chelation therapy, prior to performing vascular surgery (along with all other treatment modalities) is in violation of the doctrine of informed consent. Withholding information about a form of treatment may be tantamount to medical malpractice, if as a result, a patient is deprived of possible benefit. Thus, it is the doctors who refuse to recognize and inform their patients about chelation who are risking legal liability-not those chelating practitioners informed enough to resist peer pressure and provide an innovative treatment which they feel to be the safest, the most effective and the least expensive for many of their patients.
For more detail >>>
Ultrasound Images>>>
UltraSoundIMAGES copy

UltraSoundIMAGES copy



Heart Encyclopedia>>>


Cornary Artery Diseases
Chelation Therapy
Bypass surgery
Blood Pressure
We welcome you to our practice at Heart Care Centre. We are focused on long term health and optimal health of our patients. The key word is long term health. We are dedicated to do so by Finding the Cause of Illness and Treating the Cause--rather than covering up symptoms with drugs.
The Clinic was founded by Dr.Shahid Abbas and staffed by Dr.Syed Muhammad Raza and Dr.Rashid Bhatti. It provides Preventive non-surgical and non invasive treatment of Heart and arterial diseases, Alternative, complementary, and integrative medicine, with an emphasis on evidence based scientific therapies to enhance patients' inherent ability to heal, to sustain vigorous health, and to avoid premature aging. Specialties include EDTA chelation therapy, Nutrition & Hyper alimentation, Oxygen Therapy, Immuno-modulation & Immunotherapy for different allergies and allergic related diseases, primary care, geriatrics, internal medicine, family medicine, age management, chronic fatigue syndrome, fibromyalgia and preventive medicine